Constitutive activity at serotonin 5-HT1D receptors:: detection by homologous GTPγS versus [35S]-GTPγS binding isotherms

被引:25
作者
Audinot, V [1 ]
Newman-Tancredi, A [1 ]
Millan, MJ [1 ]
机构
[1] Inst Rech Servier, Dept Psychopharmacol, F-78290 Paris, France
关键词
5-HT1D receptor; constitutive activity; S-35]-GTP gamma S; inverse agonist;
D O I
10.1016/S0028-3908(00)00104-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although many G-protein-coupled receptors (GPCRs) may display constitutive activity, their detection has, to date, depended on the use of inverse agonists. The present study exploited a novel procedure:to investigate constitutive activity at recombinant human (h) serotonin (5-HT) 5-HT1D receptors stably expressed in Chinese hamster ovary (CHO) cells. 5-HT modestly stimulated guanosine-5'-0-(3-[S-35]thio)-triphosphate ([S-35]-GTP gammaS) binding to CHO-h5-HT1D membranes whereas methiothepin and the 5-HT1B/1D-selective ligand, SB224,289, exerted robust inhibition of basal [S-35]-GTP gammaS binding (inverse agonism). These actions were specific inasmuch as they were reversed by the novel, selective 5-HT1B/1D ligand, S18127. Constitutive activity was investigated by homologous inhibition of [S-35]-GTP gammaS binding to CHO-h5-HT1D membranes with unlabelled GTP gammaS. Under 'basal' conditions (absence of receptor ligand), biphasic isotherms were observed. Most (80%) [S-35]-GTP gammaS binding sites were in the high affinity (HA) versus low affinity (LA) component of the isotherms. HA binding was augmented by 5-HT (to 155%; relative to basal values=100%), but decreased by methiothepin (to 23%) and by SB224,289 (to 67%). In contrast, LA binding was not altered. Further, membranes of untransfected CHO cells exhibited only LA binding sites, indicating that the latter are not related to h5-HT1D receptor-G-protein coupling. Thus, at 5-HT1D receptors expressed in this CHO cell line, HA binding detected in homologous inhibition experiments (GTP gammaS versus [S-35]-GTP gammaS) under basal conditions provides a measure of constitutive G-protein activation. Thus, it is suggested that for h5-HT1D receptors and, possibly, other GPCRs, inverse agonists will be detectable by [S-35]-GTP gammaS binding if a HA component is present under basal conditions. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:57 / 64
页数:8
相关论文
共 42 条
[1]   Binding profile of the novel 5-HT1B/1D receptor antagonist, [H-3]GR 125,743, in guinea-pig brain: A comparison with [H-3]5-carboxamidotryptamine [J].
Audinot, V ;
Lochon, S ;
NewmanTancredi, A ;
Lavielle, G ;
Millan, MJ .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 327 (2-3) :247-256
[2]  
BIRNBAUMER L, 1995, J RECEPT SIGNAL TR R, V15, P213
[3]   COUPLING OF M-CHOLINOCEPTORS AND A(1) ADENOSINE RECEPTORS IN HUMAN MYOCARDIUM [J].
BOHM, M ;
GIERSCHIK, P ;
SCHWINGER, RHG ;
UHLMANN, R ;
ERDMANN, E .
AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (05) :H1951-H1958
[4]   PHYSIOLOGICAL-EFFECTS OF INVERSE AGONISTS IN TRANSGENIC MICE WITH MYOCARDIAL OVEREXPRESSION OF THE BETA(2)-ADRENOCEPTOR [J].
BOND, RA ;
LEFF, P ;
JOHNSON, TD ;
MILANO, CA ;
ROCKMAN, HA ;
MCMINN, TR ;
APPARSUNDARAM, S ;
HYEK, MF ;
KENAKIN, TP ;
ALLEN, LF ;
LEFKOWITZ, RJ .
NATURE, 1995, 374 (6519) :272-276
[5]   Cannabinoid receptor agonist efficacy for stimulating [35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity [J].
Breivogel, CS ;
Selley, DE ;
Childers, SR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) :16865-16873
[6]  
COSTA T, 1992, MOL PHARMACOL, V41, P549
[7]   Characterization of human serotonin in and 1B receptors using [H-3]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist [J].
Domenech, T ;
Beleta, J ;
Palacios, JM .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 356 (03) :328-334
[8]   Pharmacological analysis of dopamine stimulation of [S-35]-GTP gamma S binding via human D-2short and D-2long dopamine receptors expressed in recombinant cells [J].
Gardner, B ;
Hall, DA ;
Strange, PG .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) :1544-1550
[9]   The selective 5-HT1B receptor inverse agonist 1′-methyl-5[[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydrospiro[furo[2,3-f]indole-3,4′-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivo [J].
Gaster, LM ;
Blaney, FE ;
Davies, S ;
Duckworth, DM ;
Ham, P ;
Jenkins, S ;
Jennings, AJ ;
Joiner, GF ;
King, FD ;
Mulholland, KR ;
Wyman, PA ;
Hagan, JJ ;
Hatcher, J ;
Jones, BJ ;
Middlemiss, DN ;
Price, GW ;
Riley, G ;
Roberts, C ;
Routledge, C ;
Selkirk, J ;
Slade, PD .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (08) :1218-1235
[10]   G protein-coupled receptors - II. Mechanism of agonist activation [J].
Gether, U ;
Kobilka, BK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) :17979-17982